Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CML

Leukemia Research

Volumn 28, Issue 4, 2004, Pages 345-348

  Brizard, Françoise ^a   Cividin, Marie ^a   Villalva, Claire ^a   Guilhot, François ^a   Brizard, André ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Accelerated phase; Blast crisis; CML; M FISH

Indexed keywords

ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CANCER RESEARCH; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

EID: 1042277756     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.08.005     Document Type: Article

References (22)

1. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescent and Giemsa staining. Nature. 243:1973;290-293.
2. Faderl S., Talpaz M., Estrov Z., O'Brien S., Kurzrock R., Kantarjian H. The biology of chronic myeloid leukemia. N. Engl. J. Med. 341:1999;164-172.
3. Speicher M.R., Ballard S.G., Ward D.E. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat. Genet. 12:1996;368-375.
4. Jalal S.M., Law M.E. Utility of multicolor fluorescent in situ hybridization in clinical cytogenetics. Genet. Med. 1:1999;182-186.
5. Gribble S.M., Roberts I., Grace C., Andrews K.M., Green A.R., Nacheva E.P. Cytogenetics of the chronic myeloid leukemia-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence In situ hybridization. Cancer Genet Cytogenet. 118:2000;1-8.
6. Sait S.N.-J., Qadir M.U., Conroy J.M., Matsui S.I., Nowak N.J., Baer M.R. Double minute chromosome in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification region by fluorescent in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer. 34:2002;42-47.
7. Veldman T., Vignon C., Schröck E., Rowley J.D., Ried T. Hidden chromosome abnormalities in hematological malignancies detected by multicolor spectral karyotyping. Nat. Genet. 15:1997;406-410.
8. Fleischman E.W., Reshmi S., Sokova O.I., Kirichenko O.P., Konstantinova L.N., Kulagina O.E.et al. Increased Karyotype precision using fluorescent in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet. 108:1999;166-170.
9. Hilgenfeld E., Padilla-Nash H., McNeil N., Knutsen T., Montagna C., Tchinda J.et al. Spectral karyotyping and fluoresent in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of MYC oncogene in acute myeloid leukaemia M2. Br. J. Haematol. 113:2001;305-317.
10. Harrison C.J., Gibbons B., Yang F., Butler T., Cheung K.L., Kearney L.et al. Multiplex fluorescence in situ hybridization and cross species color banding of a case of chronic myeloid leukemia in blastic crisis with a complex Philadelphia translocation. Cancer Genet Cytogenet. 116(2):2000;105-110.
11. Calabrese G., Fantasia D., Franch P.G., Morizio E., Stuppia L., Gatta V.et al. Spectral karyotyping (SKY) refinement of a complex karyotype with t(2021) in a Ph-positive CML patient submitted to peripheral blood stem cell transplantation. Cancer Genet Cytogenet. 116(2):2000;105-110.
12. Barbouti A., Johansson B., Höglund M., Mauritzson N., Strömbeck B., Nilsson P.G.et al. Multicolor CBRA-FISH analysis reveals novel cryptic balanced translocations during disease progression. Genes Chromosomes Cancer. 35:2002;127-137.
13. Speck B., Bortin M.M., Champlin R., Goldman J.M., Herzig R.H., Mc Glave P.B.et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia. Lancet. 1:1984;665-668.
14. Sokal J.E., Cox E.B., Baccarani M., Tura S., Gomez G.A., Robertson J.E. et al. Prognostic discrimination "good-risk" chronic granulocytic leukemia. Cancer. 59:1984;197-202.
15. Kantarjian H.M., Dixon D., Keating M., Talpaz M., Walters R.S., Mac Credie K.B.et al. Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer. 61:1988;1441-1446.
16. Mitelman F, editor. ISCN, An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger, 1995.
17. Romana S.P., Le Coniat M., Berger R. t(1221): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer. 9:1994;186-191.
18. Mohr B., Bornhäuser M., Thiede C., Schäkel U., Schaich M., Illmer T.et al. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia. 14:2000;1031-1038.
19. Jalal S.M., Law M.E., Stamberg J., Fonseca R., Seely J.R., Myers W.H.et al. Detection of diagnostically critical, often hidden, anomalies in complex karyotypes of haematological disorders using multicolor fluorescent in situ hybridization. Br. J. Haematol. 112:2001;975-980.
20. Mrozek K., Heinonen K., Theil K.S., Bloomfield C.D. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. Genes Chromosomes Cancer. 34:2002;137-153.
21. Mehra S., Messner H., Minden M., Chaganti R.S.K. Molecular cytogenetis characterization of non-Hodking lymphoma cell lines. Genes Chromosomes Cancer. 33:2002;225-234.
22. Sawyer J.R., Lukacs J.L., Munshi N., Desikan R., Singhal S., Mehta J.et al. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood. 92:1998;4269-4278.